Chesterfield, MO, United States of America

R Saul Levinson

USPTO Granted Patents = 31 


Average Co-Inventor Count = 3.6

ph-index = 22

Forward Citations = 1,161(Granted Patents)


Location History:

  • West Milford, NJ (US) (1984)
  • Saline, MI (US) (1993 - 1994)
  • Chasterfield, MO (US) (2003)
  • Chesterfield, MO (US) (1996 - 2017)

Company Filing History:


Years Active: 1984-2017

Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: R Saul Levinson: Innovator in Pharmaceutical Delivery Systems

Introduction:

R Saul Levinson, based in Chesterfield, MO, is a renowned inventor recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 31 patents, he has demonstrated exceptional expertise in developing innovative solutions that cater to various medical needs.

Latest Patents:

Among his latest innovations, Levinson has developed a groundbreaking pharmaceutical delivery system aimed at treating vaginal conditions in human patients. This formulation introduces novel calcium compositions, featuring a granulation that comprises approximately 95% to about 99% by weight calcium carbonate. The invention incorporates about 0.5% to about 5% by weight of a binder and about 0.03% to about 3% by weight of a porosity increasing agent, resulting in a smaller tablet that enhances swallowing ease compared to traditional calcium carbonate compositions. Additionally, a pharmaceutical or nutritional composition derived from this granulation includes about 90% to about 99% by weight calcium carbonate, maintaining the advantages of his innovative approach.

Career Highlights:

Throughout his career, R Saul Levinson has made substantial contributions while working with reputable companies such as Drugtech Corporation and K.V. Pharmaceutical Company. His roles in these organizations have allowed him to refine his skills and focus on developing effective pharmaceutical solutions.

Collaborations:

Levinson has collaborated with notable professionals in the industry, including Mitchell I Kirschner and Robert C Cuca. These partnerships have played a vital role in fostering innovation and advancing the field of pharmaceutical development.

Conclusion:

R Saul Levinson remains an influential figure in the realm of pharmaceutical innovations. His dedication to creating practical and effective solutions, as demonstrated through his extensive patent portfolio, showcases his commitment to improving patient care and outcomes in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…